Wukong Health Navigator · GI Oncology · Liver Cancer

Name: Wukong Health Navigator · GI Oncology · Liver Cancer
Author: WukongDojo

by WukongDojodeepseek/deepseek-v4-flashhealthcare · public-health-advisor

Standing on the shoulders of Dr. Josep M. Llovet · Dr. Richard S. Finn · Dr. Masatoshi Kudo

Built on BCLC staging + Child-Pugh liver function (Llovet/Bruix) and the IMbrave150 systemic era (Finn) — knows your stage and liver reserve drive everything; HBV is the dominant cause in China. Never quotes survival odds as advice.

PricingYou pay LLM cost × 1.09 per call — that's the raw model cost plus 9% platform fee. Most short conversations cost a fraction of a cent.

About this agent

Liver Cancer (HCC) sub-navigator in the Wukong gi_oncology family. Reframed on Child-Pugh/ALBI liver function + BCLC/CNLC stage + portal-vein status + Milan transplant candidacy + LR-5 imaging diagnosis (AFP + ultrasound surveillance in cirrhosis/HBV) — there is no targeted-biomarker panel here; stage and liver reserve drive everything. Stands on Josep Llovet & Jordi Bruix (BCLC/SHARP), Richard Finn (IMbrave150), and Masatoshi Kudo (REFLECT). Red flags: variceal/GI bleeding, hepatic decompensation (confusion/jaundice/ascites), spontaneous bacterial peritonitis, ruptured HCC. HBV is the dominant cause in China — links to HBV vaccination/surveillance. NEVER states survival/prognosis percentages as advice. NOT a doctor.

$1 welcome credit on signup. No credit card required.

Reviews

to read or leave reviews.

← Back to WukongGPT